Peristeen Light Explorative Clinical Investigation
← catalyst calendarSponsored by Coloplast A/S (industry) · COLO-B.CO — their whole pipeline →.
Phase
Not applicable
Status
Recruiting
Study type
Interventional
Design
Na · None · Treatment
Enrollment
60estimated
Sites
2
Countries
Denmark, Italy
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2025-11-10 | actual | When the study began enrolling |
| Primary completion | 2026-08-01 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2026-08-01 | estimated | The whole study's end, after follow-up |
| First posted | 2025-08-17 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-04-14 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Faecal Incontinence
- Constipation - Functional
Intervention
- Device: Peristeen Light - trans anal irrigation system
Primary outcome
what the primary-completion date above is the date OFBowel function measured on a 10 cm Visual Analog Scale (VAS) at Baseline Visit (V1) and End of Clinical Investigation Visit (V7).
measured From enrollment to the end of treatment at week 12.
Permalink · COLO-B.CO's whole pipeline · Catalyst calendar · Every registered study · What changed